RASSF6 Antikörper (Middle Region)
Kurzübersicht für RASSF6 Antikörper (Middle Region) (ABIN1450095)
Target
Alle RASSF6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- 14 amino acid synthetic peptide near the center of Human RASSF6
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C.
-
-
- RASSF6 (Ras Association Domain-Containing Protein 6 (RASSF6))
-
Andere Bezeichnung
- RASSF6
-
Hintergrund
- RASSF family proteins are tumor suppressors that are frequently downregulated during the development of human cancer. RASSF6 (Ras association (RalGDS/AF-6) domain family member 6), a member of RASSF family, acts as a Ras effector protein / tumor suppressor. RASSF6 contains one Ras-associating domain and one SARAH domain. It is involved in the induction of apoptosis, through both caspase-dependent and caspase-independent pathways. Defects in RASSF6 may facilitate viral NFk-B pathway and may play a vital role in infection.Synonyms: Ras association domain-containing protein 6
-
Gen-ID
- 166824
-
NCBI Accession
- NP_803876
Target
-